Per Lund
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer-related Molecular Pathways
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- DNA Repair Mechanisms 1
- CRISPR and Genetic Engineering 1
- Oncology 4
- Clusterin in disease pathology 1
- Co-authors
- Christine Sers (4 shared papers)Peter Schirmacher (2 shared papers)Reinhold Schäfer (3 shared papers)Felix Geißler (1 shared paper)H. P. Dienes (1 shared paper)Wolfgang H. Caselmann (1 shared paper)Karsten Schlüns (1 shared paper)Hiroaki Yasumoto (1 shared paper)
- Journals
- Oncogene (2 papers)Molecular Cancer Therapeutics (1 paper)Mutation research. Fundamental and molecular mechanisms of mutagenesis (1 paper)International Journal of Cancer (1 paper)Lab on a Chip (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Per Lund
9 papers receiving 467 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 113
- Oncology 147
- Molecular Biology 245
- Hepatology 24
- Immunology 63
Countries citing papers authored by Per Lund
This map shows the geographic impact of Per Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Lund more than expected).
Fields of papers citing papers by Per Lund
This network shows the impact of papers produced by Per Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Lund. The network helps show where Per Lund may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Lund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 68 | |
| 2 | 2007 | 66 | |
| 3 | 2009 | 63 | |
| 4 | 2004 | 60 | |
| 5 | 2001 | 60 | |
| 6 | 2006 | 59 | |
| 7 | 2003 | 42 | |
| 8 | 1998 | 38 | |
| 9 | 2011 | 16 |
About Per Lund
Per Lund is a scholar working on Molecular Biology, Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism and Genetics, having authored 9 papers that have together received 472 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Carcinogens and Genotoxicity Assessment (1 paper), DNA Repair Mechanisms (1 paper), CRISPR and Genetic Engineering (1 paper), Cancer Genomics and Diagnostics (1 paper), Genetic Syndromes and Imprinting (1 paper) and Clusterin in disease pathology (1 paper). The work is most often cited by research in Cancer Research (113 citations), Oncology (147 citations), Molecular Biology (245 citations), Hepatology (24 citations) and Immunology (63 citations). Per Lund has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Christine Sers, Peter Schirmacher, Reinhold Schäfer, Felix Geißler, H. P. Dienes, Wolfgang H. Caselmann, Karsten Schlüns, Hiroaki Yasumoto, André Rosenthal and Irene Petersen. Their work appears in journals such as Oncogene, Molecular Cancer Therapeutics, Mutation research. Fundamental and molecular mechanisms of mutagenesis, International Journal of Cancer and Lab on a Chip.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.